Kurbatov L, Radko S, Khmeleva S, Timoshenko O, Lisitsa A. Evaluation of the Collateral Activity of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer. BIOMED CHEM RM [Internet]. 2022 Jun. 30 [cited 2024 Dec. 4];5(2):e00169. Available from: http://bmc-rm.org/index.php/BMCRM/article/view/169